ZasocitinibA Study of Zasocitinib in Adults With Nonsegmental Vitiligo

Sponsor:

Takeda

Code:

NCT07108283

Conditions

Nonsegmental Vitiligo

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Zasocitinib

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-24. This information was provided to ClinicalTrials.gov by Takeda on 2026-08-14.